NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.90
−2.62%Margins
Gross margin
-919.5%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-43.1%
Return on equity
-34.6%
Return on assets
-39.5%
Return on invested capital
0.00x
Asset turnover
-$50.2M
Cash from operations
$0.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026